DERMAPHARM HOLDING SE (DMP.DE) Stock Fundamental Analysis
Europe - FRA:DMP - DE000A2GS5D8 - Common Stock
33.075 EUR
+0.08 (+0.23%)
Overall DMP gets a fundamental rating of 5 out of 10. We evaluated DMP against 53 industry peers in the Pharmaceuticals industry. DMP has a medium profitability rating, but doesn't score so well on its financial health evaluation. DMP is not valued too expensively and it also shows a decent growth rate.
1. Profitability
1.1 Basic Checks
In the past year DMP was profitable.
DMP had a positive operating cash flow in the past year.
Each year in the past 5 years DMP has been profitable.
DMP had a positive operating cash flow in each of the past 5 years.
1.2 Ratios
DMP has a Return On Assets (5.02%) which is in line with its industry peers.
DMP has a better Return On Equity (17.62%) than 62.26% of its industry peers.
Looking at the Return On Invested Capital, with a value of 7.50%, DMP is in line with its industry, outperforming 47.17% of the companies in the same industry.
DMP had an Average Return On Invested Capital over the past 3 years of 9.78%. This is below the industry average of 14.46%.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 5.02% | ||
| ROE | 17.62% | ||
| ROIC | 7.5% |
ROA(3y)5.95%
ROA(5y)7.95%
ROE(3y)18.55%
ROE(5y)24.89%
ROIC(3y)9.78%
ROIC(5y)10.35%
1.3 Margins
DMP has a Profit Margin of 9.11%. This is comparable to the rest of the industry: DMP outperforms 45.28% of its industry peers.
DMP's Profit Margin has declined in the last couple of years.
DMP has a Operating Margin (18.55%) which is in line with its industry peers.
In the last couple of years the Operating Margin of DMP has grown nicely.
Looking at the Gross Margin, with a value of 65.67%, DMP is in line with its industry, outperforming 41.51% of the companies in the same industry.
DMP's Gross Margin has improved in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 18.55% | ||
| PM (TTM) | 9.11% | ||
| GM | 65.67% |
OM growth 3Y-14.93%
OM growth 5Y2.07%
PM growth 3Y-24.31%
PM growth 5Y-2.64%
GM growth 3Y-0.44%
GM growth 5Y3.48%
2. Health
2.1 Basic Checks
With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), DMP is creating some value.
DMP has about the same amout of shares outstanding than it did 1 year ago.
Compared to 5 years ago, DMP has about the same amount of shares outstanding.
Compared to 1 year ago, DMP has a worse debt to assets ratio.
2.2 Solvency
An Altman-Z score of 2.05 indicates that DMP is not a great score, but indicates only limited risk for bankruptcy at the moment.
DMP has a worse Altman-Z score (2.05) than 60.38% of its industry peers.
DMP has a debt to FCF ratio of 5.76. This is a neutral value as DMP would need 5.76 years to pay back of all of its debts.
With a Debt to FCF ratio value of 5.76, DMP perfoms like the industry average, outperforming 41.51% of the companies in the same industry.
A Debt/Equity ratio of 1.52 is on the high side and indicates that DMP has dependencies on debt financing.
DMP's Debt to Equity ratio of 1.52 is on the low side compared to the rest of the industry. DMP is outperformed by 75.47% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.52 | ||
| Debt/FCF | 5.76 | ||
| Altman-Z | 2.05 |
ROIC/WACC1.24
WACC6.04%
2.3 Liquidity
DMP has a Current Ratio of 1.84. This is a normal value and indicates that DMP is financially healthy and should not expect problems in meeting its short term obligations.
The Current ratio of DMP (1.84) is better than 71.70% of its industry peers.
DMP has a Quick Ratio of 1.84. This is a bad value and indicates that DMP is not financially healthy enough and could expect problems in meeting its short term obligations.
The Quick ratio of DMP (0.87) is comparable to the rest of the industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.84 | ||
| Quick Ratio | 0.87 |
3. Growth
3.1 Past
DMP shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 29.17%, which is quite impressive.
DMP shows quite a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 8.07% yearly.
The Revenue has been growing slightly by 3.98% in the past year.
DMP shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 11.00% yearly.
EPS 1Y (TTM)29.17%
EPS 3Y-18.42%
EPS 5Y8.07%
EPS Q2Q%21.61%
Revenue 1Y (TTM)3.98%
Revenue growth 3Y7.79%
Revenue growth 5Y11%
Sales Q2Q%-2.74%
3.2 Future
The Earnings Per Share is expected to grow by 14.13% on average over the next years. This is quite good.
Based on estimates for the next years, DMP will show a small growth in Revenue. The Revenue will grow by 2.70% on average per year.
EPS Next Y13%
EPS Next 2Y11.96%
EPS Next 3Y11.07%
EPS Next 5Y14.13%
Revenue Next Year-0.58%
Revenue Next 2Y1.65%
Revenue Next 3Y2.36%
Revenue Next 5Y2.7%
3.3 Evolution
When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
4. Valuation
4.1 Price/Earnings Ratio
The Price/Earnings ratio is 16.62, which indicates a correct valuation of DMP.
DMP's Price/Earnings ratio is in line with the industry average.
The average S&P500 Price/Earnings ratio is at 26.03. DMP is valued slightly cheaper when compared to this.
With a Price/Forward Earnings ratio of 12.90, DMP is valued correctly.
Compared to the rest of the industry, the Price/Forward Earnings ratio of DMP indicates a somewhat cheap valuation: DMP is cheaper than 62.26% of the companies listed in the same industry.
DMP's Price/Forward Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 22.27.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 16.62 | ||
| Fwd PE | 12.9 |
4.2 Price Multiples
Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of DMP indicates a somewhat cheap valuation: DMP is cheaper than 77.36% of the companies listed in the same industry.
DMP's Price/Free Cash Flow ratio is rather cheap when compared to the industry. DMP is cheaper than 88.68% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 10.15 | ||
| EV/EBITDA | 8.63 |
4.3 Compensation for Growth
The PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
PEG (NY)1.28
PEG (5Y)2.06
EPS Next 2Y11.96%
EPS Next 3Y11.07%
5. Dividend
5.1 Amount
DMP has a Yearly Dividend Yield of 2.65%.
DMP's Dividend Yield is a higher than the industry average which is at 2.99.
Compared to an average S&P500 Dividend Yield of 2.38, DMP has a dividend comparable with the average S&P500 company.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 2.65% |
5.2 History
The dividend of DMP has a limited annual growth rate of 2.71%.
Dividend Growth(5Y)2.71%
Div Incr Years1
Div Non Decr Years1
5.3 Sustainability
44.20% of the earnings are spent on dividend by DMP. This is a bit on the high side, but may be sustainable.
DMP's earnings are growing more than its dividend. This makes the dividend growth sustainable.
DP44.2%
EPS Next 2Y11.96%
EPS Next 3Y11.07%
FRA:DMP (11/5/2025, 5:29:33 PM)
33.075
+0.08 (+0.23%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryPharmaceuticals
Earnings (Last)
Earnings (Next)
Inst Owners12.94%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap1.78B
Revenue(TTM)1.18B
Net Income(TTM)107.20M
Analysts78.18
Price Target43.25 (30.76%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 2.65% |
Yearly Dividend0.88
Dividend Growth(5Y)2.71%
DP44.2%
Div Incr Years1
Div Non Decr Years1
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)-6.61%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)-1.37%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)-1%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 16.62 | ||
| Fwd PE | 12.9 | ||
| P/S | 1.51 | ||
| P/FCF | 10.15 | ||
| P/OCF | 8.26 | ||
| P/B | 2.93 | ||
| P/tB | N/A | ||
| EV/EBITDA | 8.63 |
EPS(TTM)1.99
EY6.02%
EPS(NY)2.56
Fwd EY7.75%
FCF(TTM)3.26
FCFY9.85%
OCF(TTM)4
OCFY12.1%
SpS21.86
BVpS11.3
TBVpS-8.64
PEG (NY)1.28
PEG (5Y)2.06
Graham Number22.49
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 5.02% | ||
| ROE | 17.62% | ||
| ROCE | 12.3% | ||
| ROIC | 7.5% | ||
| ROICexc | 8.28% | ||
| ROICexgc | 24.86% | ||
| OM | 18.55% | ||
| PM (TTM) | 9.11% | ||
| GM | 65.67% | ||
| FCFM | 14.9% |
ROA(3y)5.95%
ROA(5y)7.95%
ROE(3y)18.55%
ROE(5y)24.89%
ROIC(3y)9.78%
ROIC(5y)10.35%
ROICexc(3y)10.97%
ROICexc(5y)11.73%
ROICexgc(3y)29.64%
ROICexgc(5y)29.05%
ROCE(3y)16.03%
ROCE(5y)16.96%
ROICexgc growth 3Y-9.69%
ROICexgc growth 5Y2.94%
ROICexc growth 3Y-20.13%
ROICexc growth 5Y-1%
OM growth 3Y-14.93%
OM growth 5Y2.07%
PM growth 3Y-24.31%
PM growth 5Y-2.64%
GM growth 3Y-0.44%
GM growth 5Y3.48%
F-Score8
Asset Turnover0.55
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.52 | ||
| Debt/FCF | 5.76 | ||
| Debt/EBITDA | 3.05 | ||
| Cap/Depr | 47.34% | ||
| Cap/Sales | 3.41% | ||
| Interest Coverage | 4.1 | ||
| Cash Conversion | 71.11% | ||
| Profit Quality | 163.6% | ||
| Current Ratio | 1.84 | ||
| Quick Ratio | 0.87 | ||
| Altman-Z | 2.05 |
F-Score8
WACC6.04%
ROIC/WACC1.24
Cap/Depr(3y)41.99%
Cap/Depr(5y)70.86%
Cap/Sales(3y)3.57%
Cap/Sales(5y)4.47%
Profit Quality(3y)204.39%
Profit Quality(5y)161.92%
High Growth Momentum
Growth
EPS 1Y (TTM)29.17%
EPS 3Y-18.42%
EPS 5Y8.07%
EPS Q2Q%21.61%
EPS Next Y13%
EPS Next 2Y11.96%
EPS Next 3Y11.07%
EPS Next 5Y14.13%
Revenue 1Y (TTM)3.98%
Revenue growth 3Y7.79%
Revenue growth 5Y11%
Sales Q2Q%-2.74%
Revenue Next Year-0.58%
Revenue Next 2Y1.65%
Revenue Next 3Y2.36%
Revenue Next 5Y2.7%
EBIT growth 1Y14.2%
EBIT growth 3Y-8.31%
EBIT growth 5Y13.3%
EBIT Next Year57.14%
EBIT Next 3Y20.11%
EBIT Next 5Y7.48%
FCF growth 1Y-34.18%
FCF growth 3Y-4.81%
FCF growth 5Y24.67%
OCF growth 1Y-28.97%
OCF growth 3Y-7%
OCF growth 5Y14.89%
DERMAPHARM HOLDING SE / DMP.DE FAQ
What is the fundamental rating for DMP stock?
ChartMill assigns a fundamental rating of 5 / 10 to DMP.DE.
What is the valuation status for DMP stock?
ChartMill assigns a valuation rating of 5 / 10 to DERMAPHARM HOLDING SE (DMP.DE). This can be considered as Fairly Valued.
How profitable is DERMAPHARM HOLDING SE (DMP.DE) stock?
DERMAPHARM HOLDING SE (DMP.DE) has a profitability rating of 5 / 10.
Can you provide the PE and PB ratios for DMP stock?
The Price/Earnings (PE) ratio for DERMAPHARM HOLDING SE (DMP.DE) is 16.62 and the Price/Book (PB) ratio is 2.93.
What is the earnings growth outlook for DERMAPHARM HOLDING SE?
The Earnings per Share (EPS) of DERMAPHARM HOLDING SE (DMP.DE) is expected to grow by 13% in the next year.